⏱ 3 min read
Under the label of metabolic precursors are grouped compounds that sustain central processes of the body —energy, antioxidant defense, fat transport— and that share one characteristic: the body makes them from amino acids, so often the best way to increase them is not to take them directly, but to provide their limiting precursor.
The best-studied example is creatine, which the body synthesizes in the liver and kidney by combining three amino acids: glycine, arginine, and methionine. Creatine stores fast energy in muscle and brain in the form of phosphocreatine, ready to regenerate ATP in intense efforts. Although the body produces it, endogenous synthesis covers only part of what can be stored, which is why creatine supplementation is among the best supported by evidence.
Glutathione is the main antioxidant made by the cell, a tripeptide of cysteine, glutamate, and glycine. Of the three, the limiting amino acid is almost always cysteine, and therein lies the practical key: taking glutathione orally is inefficient because it is degraded in digestion, whereas supplying its cysteine precursor —N-acetylcysteine (NAC)— raises glutathione production far more reliably. It is the perfect illustration of the principle of this section: when the end product is not well absorbed, the limiting precursor is supplemented.
Carnitine is essential for bringing long-chain fatty acids into the mitochondria, where they are burned for energy. The body synthesizes it from lysine and methionine, with vitamin C as a cofactor, and also obtains it from meat. In healthy omnivores it is rarely lacking, but its role as a precursor of energy transport makes it relevant in very restrictive diets, in certain clinical conditions, and as a subject of study in performance and recovery.
These examples share a lesson that repeats throughout nutrition: in a pathway with several ingredients, what rules is the one in short supply. Providing glycine or glutamate does not raise glutathione if what is lacking is cysteine; loading up on arginine does not increase creatine if the bottleneck is at another step. Identifying and supplementing the limiting link —rather than the end product or the ingredients that are already abundant— is what turns a precursor into a useful intervention.
Educational information, not medical advice.